Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?
Maham Fatima
Sat, February 14, 2026 at 3:21 PM GMT+9 1 min read
In this article:
ALNY
+1.92%
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best upside stocks to invest in right now. On January 30, Bank of America lowered its price target on Alnylam to $462 from $529 while maintaining a Buy rating as part of the firm’s Q4 2025 small-to-mid cap biotech earnings preview.
On the same day, H.C. Wainwright also lowered its price target on Alnylam to $510 from $570 with a Buy rating. The firm reduced its estimates to reflect a more disciplined outlook for near-term growth and margins. Despite the adjustment, the firm sees compelling upside for the shares as the TTR franchise scales and the Alnylam 2030 strategy is implemented.
On January 27, Barclays analyst Eliana Merle assumed coverage of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) with an Overweight rating and a $527 price target. This initiation was part of a broader move in which Barclays began covering 12 biotech stocks and assumed coverage of 11 others, expressing a positive outlook on the industry for 2026. Merle noted that many biotech stocks remain undervalued and anticipates that significant tailwinds will benefit the sector.
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?
Copyright: restyler / 123RF Stock Photo
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
While we acknowledge the potential of ALNY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now**.**
Disclosure: None. This article is originally published at Insider Monkey.
Terms and Privacy Policy
Privacy Dashboard
More Info